276 related articles for article (PubMed ID: 33834002)
1. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses.
Luo D; Zhao W; Lin Z; Wu J; Lin H; Li Y; Song J; Zhang J; Peng H
Front Cell Infect Microbiol; 2021; 11():579386. PubMed ID: 33834002
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the correlation between intestinal flora and peritoneal dialysis-related peritonitis.
Zhou J; Yang C; Lei W; Yang Z; Chen J; Lin H
Clin Exp Nephrol; 2022 Oct; 26(10):1030-1038. PubMed ID: 35662387
[TBL] [Abstract][Full Text] [Related]
3. Exploration of the correlation between intestinal flora and Escherichia coli peritoneal dialysis-related peritonitis.
Zhou J; Yang C; Lei W; Yang Z; Chen J; Lin H; Li Q; Yuan W
BMC Nephrol; 2022 Feb; 23(1):76. PubMed ID: 35193514
[TBL] [Abstract][Full Text] [Related]
4. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
[TBL] [Abstract][Full Text] [Related]
5. Correlation between intestinal flora disruption and protein-energy wasting in patients with end-stage renal disease.
Hu J; Zhong X; Liu Y; Yan J; Zhou D; Qin D; Xiao X; Zheng Y; Wen L; Tan R; Liang P; Liu Y
BMC Nephrol; 2022 Apr; 23(1):130. PubMed ID: 35369865
[TBL] [Abstract][Full Text] [Related]
6. High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients.
Hu J; Zhong X; Yan J; Zhou D; Qin D; Xiao X; Zheng Y; Liu Y
BMC Nephrol; 2020 Jan; 21(1):12. PubMed ID: 31931722
[TBL] [Abstract][Full Text] [Related]
7. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.
Bao M; Zhang P; Guo S; Zou J; Ji J; Ding X; Yu X
Front Cell Infect Microbiol; 2022; 12():639624. PubMed ID: 36237423
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.
Yacoub R; Nugent M; Cai W; Nadkarni GN; Chaves LD; Abyad S; Honan AM; Thomas SA; Zheng W; Valiyaparambil SA; Bryniarski MA; Sun Y; Buck M; Genco RJ; Quigg RJ; He JC; Uribarri J
PLoS One; 2017; 12(9):e0184789. PubMed ID: 28931089
[TBL] [Abstract][Full Text] [Related]
9. Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis.
Wang J; Wu S; Zhang J; Li Y; Wu Y; Qi X
BMC Nephrol; 2023 Dec; 24(1):360. PubMed ID: 38053016
[TBL] [Abstract][Full Text] [Related]
10. In-Hospital Mortality in Cirrhotic Patients with End-Stage Renal Disease Treated with Hemodialysis Versus Peritoneal Dialysis: A Nationwide Study.
Nader MA; Aguilar R; Sharma P; Krishnamoorthy P; Serban D; Gordon-Cappitelli J; Shen W; Nilubol C; Li P; Lipkowitz M
Perit Dial Int; 2017; 37(4):464-471. PubMed ID: 28348101
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics associated with the properties of gut microbiota in peritoneal dialysis patients.
Jiang N; Zhang C; Feng H; Yuan J; Ding L; Fang W; Gu A; Huang J; Li N; Gu L; Ni Z; Mou S
Perit Dial Int; 2021 May; 41(3):298-306. PubMed ID: 33272119
[TBL] [Abstract][Full Text] [Related]
12. Comparison Between Hemodialysis and Peritoneal Dialysis in the Risks for Disease Activity in LN-ESRD Patients: A Systematic Review and Meta-analysis.
Gong Y; Zhao Y; Ran L; Liu Y
Altern Ther Health Med; 2022 Sep; 28(6):144-149. PubMed ID: 35648699
[TBL] [Abstract][Full Text] [Related]
13. Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages.
Li J; Xing H; Lin W; Yu H; Yang B; Jiang C; Zhang J; Wu R; Ding F; Pei M; Yang H
Front Med (Lausanne); 2023; 10():1302352. PubMed ID: 38249961
[TBL] [Abstract][Full Text] [Related]
14. Uremic Toxin-Producing
Shivani S; Kao CY; Chattopadhyay A; Chen JW; Lai LC; Lin WH; Lu TP; Huang IH; Tsai MH; Teng CH; Wu JJ; Hsieh YH; Wang MC; Chuang EY
Front Cell Infect Microbiol; 2022; 12():726256. PubMed ID: 35558102
[TBL] [Abstract][Full Text] [Related]
15. Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients.
He H; Xie Y
Biomed Res Int; 2020; 2020():6739762. PubMed ID: 32685517
[TBL] [Abstract][Full Text] [Related]
16. The effects of Fushen Granule on the composition and function of the gut microbiota during Peritoneal Dialysis-Related Peritonitis.
Lin W; Jiang C; Yu H; Wang L; Li J; Liu X; Wang L; Yang H
Phytomedicine; 2021 Jun; 86():153561. PubMed ID: 33857850
[TBL] [Abstract][Full Text] [Related]
17. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia.
Zhu Y; Tang Y; He H; Hu P; Sun W; Jin M; Wang L; Xu X
Front Cell Infect Microbiol; 2022; 12():919352. PubMed ID: 35937691
[TBL] [Abstract][Full Text] [Related]
19. Cerebral blood flow changes in hemodialysis and peritoneal dialysis patients: an arterial-spin labeling MR imaging.
Jiang XL; Wen JQ; Zhang LJ; Zheng G; Li X; Zhang Z; Liu Y; Zheng LJ; Wu L; Chen HJ; Kong X; Luo S; Lu GM; Ji XM; Zhang ZJ
Metab Brain Dis; 2016 Aug; 31(4):929-36. PubMed ID: 27167984
[TBL] [Abstract][Full Text] [Related]
20. Clostridium species diversity in gut microbiota of patients with renal failure.
Khiabani SA; Haghighat S; Khosroshahi HT; Asgharzadeh M; Kafil HS
Microb Pathog; 2022 Aug; 169():105667. PubMed ID: 35793779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
